Purpose: The primary purpose of the CD20 test is to aid in the diagnosis and monitoring of conditions related to B-cell populations. This includes various types of lymphomas, leukemias, and autoimmune disorders such as rheumatoid arthritis. Methodology: The test typically involves collecting a blood sample from the patient, although in some cases, other bodily fluids or tissue samples may be used. The sample is then processed in a laboratory using techniques such as flow cytometry or immunohistochemistry to detect and quantify CD20 expression on the surface of B-cells. Interpretation: The results of the CD20 test provide valuable information to healthcare providers about the presence and activity of B-cells in the patient's body. Abnormal levels or patterns of CD20 expression can indicate various underlying health conditions, helping guide further diagnostic testing and treatment decisions. Clinical Applications: The CD20 test is particularly important in the diagnosis and management of B-cell malignancies such as non-Hodgkin lymphoma and chronic lymphocytic leukemia. It is also used to assess the effectiveness of certain targeted therapies that specifically target CD20-positive B-cells, such as rituximab. Limitations: While the CD20 test is a valuable tool in the evaluation of B-cell-related disorders, it is not diagnostic on its own and must be interpreted in conjunction with other clinical and laboratory findings. Additionally, CD20 expression levels can vary depending on various factors, including the stage of the disease and prior treatments.

Discomfort or pain: The test may involve drawing blood, which can cause mild discomfort or pain at the site of the needle insertion. Bruising or bleeding: After the blood draw, there may be some bruising or bleeding at the site where the needle was inserted. This is usually minor and resolves on its own. Infection: There is a very small risk of infection at the site of the blood draw, though healthcare professionals take precautions to minimize this risk by using sterile equipment and techniques. Fainting or dizziness: Some individuals may feel faint or dizzy during or after the blood draw, particularly if they are uncomfortable with needles or blood.

The CD20 test measures the presence of CD20, a protein found on the surface of B-cells. The interpretation of results would involve comparing the level of CD20 to established reference ranges and considering the clinical context.

Elevated or decreased levels of CD20 could indicate various conditions, such as B-cell lymphomas (e.g., non-Hodgkin lymphoma) or autoimmune diseases (e.g., rheumatoid arthritis). Interpretation should be done by a qualified medical professional in conjunction with other clinical findings and diagnostic tests.

The CD20 test typically requires a blood sample, collected via venipuncture.